
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14910971
[patent_doc_number] => 10426785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => C-19 steroids for inhibiting neovascularization
[patent_app_type] => utility
[patent_app_number] => 15/535461
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6499
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535461 | C-19 steroids for inhibiting neovascularization | Dec 20, 2015 | Issued |
Array
(
[id] => 11018004
[patent_doc_number] => 20160214957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES'
[patent_app_type] => utility
[patent_app_number] => 14/975484
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28767
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14975484
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/975484 | Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses | Dec 17, 2015 | Issued |
Array
(
[id] => 13661241
[patent_doc_number] => 10160772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
[patent_app_type] => utility
[patent_app_number] => 15/524472
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18541
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524472 | 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives | Dec 17, 2015 | Issued |
Array
(
[id] => 11991636
[patent_doc_number] => 20170295792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/036316
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16213
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036316 | Use of picolinamide compounds as fungicides | Dec 17, 2015 | Issued |
Array
(
[id] => 12126228
[patent_doc_number] => 20180009813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS'
[patent_app_type] => utility
[patent_app_number] => 15/540057
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40083
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540057 | Pesticidally active tetracyclic derivatives with sulfur containing substituents | Dec 14, 2015 | Issued |
Array
(
[id] => 13702529
[patent_doc_number] => 20170362219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/527343
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 551
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527343 | Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors | Dec 13, 2015 | Issued |
Array
(
[id] => 12058583
[patent_doc_number] => 20170334927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing'
[patent_app_type] => utility
[patent_app_number] => 15/534886
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25830
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534886 | Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing | Dec 10, 2015 | Abandoned |
Array
(
[id] => 10744213
[patent_doc_number] => 20160090364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/962923
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39991
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962923
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962923 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Dec 7, 2015 | Abandoned |
Array
(
[id] => 12367116
[patent_doc_number] => 09957240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
[patent_app_type] => utility
[patent_app_number] => 15/528153
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 7742
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/528153 | Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof | Dec 7, 2015 | Issued |
Array
(
[id] => 12448374
[patent_doc_number] => 09981976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)
[patent_app_type] => utility
[patent_app_number] => 15/534442
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25068
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534442 | Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV) | Dec 6, 2015 | Issued |
Array
(
[id] => 10807809
[patent_doc_number] => 20160153965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Compounds and Method of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators'
[patent_app_type] => utility
[patent_app_number] => 14/958222
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 50110
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14958222
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/958222 | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators | Dec 2, 2015 | Issued |
Array
(
[id] => 13194103
[patent_doc_number] => 10111955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => PEG derivative
[patent_app_type] => utility
[patent_app_number] => 15/520956
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 7061
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520956
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/520956 | PEG derivative | Dec 2, 2015 | Issued |
Array
(
[id] => 13717077
[patent_doc_number] => 20170369493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/533308
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533308
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533308 | 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of MGLUR2 receptors | Dec 1, 2015 | Issued |
Array
(
[id] => 11611448
[patent_doc_number] => 09649291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Treatment for obesity'
[patent_app_type] => utility
[patent_app_number] => 14/955646
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11080
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14955646
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/955646 | Treatment for obesity | Nov 30, 2015 | Issued |
Array
(
[id] => 14360011
[patent_doc_number] => 10301292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Bicyclic compound
[patent_app_type] => utility
[patent_app_number] => 15/529816
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 84886
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/529816 | Bicyclic compound | Nov 24, 2015 | Issued |
Array
(
[id] => 12185346
[patent_doc_number] => 20180044283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'BIGUANIDE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/527621
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20366
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527621 | Biguanide compound and use thereof | Nov 19, 2015 | Issued |
Array
(
[id] => 13687387
[patent_doc_number] => 20170354648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => 1,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
[patent_app_type] => utility
[patent_app_number] => 15/527458
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527458
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527458 | 1,9-diazaspiro undecane compounds having multimodal activity against pain | Nov 19, 2015 | Issued |
Array
(
[id] => 12489828
[patent_doc_number] => 09994553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Process for the purification of the Axl tyrosine receptor kinase inhibitor "R428"
[patent_app_type] => utility
[patent_app_number] => 15/526220
[patent_app_country] => US
[patent_app_date] => 2015-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4379
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/526220 | Process for the purification of the Axl tyrosine receptor kinase inhibitor "R428" | Nov 12, 2015 | Issued |
Array
(
[id] => 12016904
[patent_doc_number] => 09809596
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-11-07
[patent_title] => 'Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis'
[patent_app_type] => utility
[patent_app_number] => 15/522336
[patent_app_country] => US
[patent_app_date] => 2015-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5716
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 893
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522336 | Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis | Nov 4, 2015 | Issued |
Array
(
[id] => 13689417
[patent_doc_number] => 20170355663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/524224
[patent_app_country] => US
[patent_app_date] => 2015-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524224
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524224 | Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods | Nov 3, 2015 | Issued |